Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 248

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 248
---
 within 60 days of February 5, 2025 and (b) 106,921 shares of Enfusion Common Stock issuable upon the settlement of RSUs releasable within 60 days of February 5, 2025. |

| (9) | Based solely on information provided in a Schedule 13D filed with the SEC on June 23, 2023, as amended by                                                                                                                                               
 a Schedule 13D/A filed with the SEC on January 14, 2025. Consists of (a) 31,297,606 shares of Enfusion Common Stock held by FTV IV, L.P. (“FTV Fund IV”) and (b) 1,142,857 shares of Enfusion Common Stock held by FTV Investment                       
 Holdings, L.P. (“FTV Holdings”). FTV Management IV, L.L.C. (“FTV Management”) is the general partner of FTV Fund IV and FTV Management Company GP, L.L.C. (“FTV GP”) is the general partner of FTV                                                      
 Holdings and FTV Management. FTV GP exercises voting and dispositive power with regard to the shares held by FTV Fund IV and FTV Holdings and may be deemed the beneficial owner of such 31,297,606 shares of Enfusion Common Stock held by FTV Fund IV 
 and 1,142,857 shares of Enfusion Common Stock held by FTV Holdings. The address for each of FTV Fund IV, FTV Holdings, FTV Management and FTV GP is 535 Madison Avenue, Floor 33, New York, NY 10022.                                                   |

| (10) | Based solely on information provided in a Schedule 13G/A filed with the SEC on October 25, 2024. Consists                                                                                                                                            
 of (a) 1,184,271 shares of Enfusion Common Stock and (b) 5,000,000 shares of Enfusion Common Stock that LRA Ventures, LLC (“LRA Ventures”) has the right to acquire upon the exchange of Common Units. Tarek Hammoud is the sole manager             
 of LRA Ventures and may be deemed the beneficial owner of such 1,184,271 shares of Enfusion Common Stock directly held by LRA Ventures and 5,000,000 shares of Enfusion Common Stock that LRA Ventures has the right to acquire upon the exchange of 
 Common Units by virtue of his position as the control person of LRA Ventures. The address for